tiprankstipranks
Avenue Therapeutics Inc (ATXI)
NASDAQ:ATXI
Holding ATXI?
Track your performance easily

Avenue Therapeutics (ATXI) Financial Statements

316 Followers

Avenue Therapeutics Financial Overview

Avenue Therapeutics's market cap is currently ―. The company's EPS TTM is $-14.198; its P/E ratio is -0.12; Avenue Therapeutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.57. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.09M$ -2.52M$ 3.64M$ 617.00K$ 513.00K
EBITDA$ -3.09M$ -2.52M$ 3.64M$ 617.00K$ 513.00K
Net Income Common Stockholders$ -3.08M$ -7.19M$ -4.34M$ 640.00K$ 526.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.60M$ 4.92M$ 3.19M$ 1.78M$ 161.00K
Total Assets$ 2.63M$ 4.99M$ 3.31M$ 1.85M$ 502.00K
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -2.60M$ -4.92M$ -3.19M$ -1.78M$ -161.00K
Total Liabilities$ 973.00K$ 1.16M$ 1.41M$ 1.20M$ 5.02M
Stockholders Equity$ 2.61M$ 4.76M$ 2.84M$ 1.58M$ -3.65M
Cash Flow-
Free Cash Flow$ -2.89M$ -2.25M$ -3.12M$ -2.32M$ -1.89M
Operating Cash Flow$ -2.89M$ -2.25M$ -3.12M$ -2.32M$ -889.00K
Investing Cash Flow----$ -1.00M
Financing Cash Flow$ 567.00K$ 3.98M$ 4.53M$ 3.95M$ 479.00K
Currency in USD

Avenue Therapeutics Earnings and Revenue History

Avenue Therapeutics Debt to Assets

Avenue Therapeutics Cash Flow

Avenue Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis